instruction stringlengths 732 1.39k | output stringlengths 651 861 |
|---|---|
SUBJECT: Cross-product clinical and quality note on Product A and supply inquiry
BODY:
Dear Clinical Lead Pharmacist,
I am the lead clinical pharmacist at a regional oncology unit and I am writing to raise two separate matters. The first is an adverse event involving Product A. The individual is a 66 year old male wit... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient showed signs of acute renal dysfunction with rising creatinine after 5 days temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Integrated feedback regarding Product A and supply inquiry
BODY:
Dear Compliance Team,
I am the quality officer at a private hospital and I am contacting you regarding two separate topics. The first is a safety report for Product A where The individual is a 35 year old female with ankylosing spondylitis and u... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient observed blood in urine after 4 days of administration temporally associated with Product A initiation, with clinical intervention taken, qualifying... |
SUBJECT: Multi-faceted problem about Product A and Product B
BODY:
Dear Compliance Team,
Our paediatric ward currently uses Product A for seizure control and Product B for adjunctive behavioural management in selected patients. and I am writing to formally raise two matters. The first concerns Product A and specifical... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you send any recent peer-revie... |
SUBJECT: Administrative and medical query on Product A and Product B
BODY:
Dear Post-Market Surveillance,
I am the senior consultant at Global Health Partners advising on the combined formulary placement of Product A for oncology supportive care and Product B for nutritional supplementation. and I wish to bring two is... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What are the infusion instructions i... |
SUBJECT: Labeling error and clinical query about Product A and Product B
BODY:
Dear Medical and Commercial Teams,
As the pharmacy director of a 500-bed tertiary hospital, I am coordinating formulary reviews for Product A in cardiology and Product B in neurology. and I am writing to report two separate issues. The firs... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient suffered profound fatigue and muscle weakness after 6 days of treatment temporally associated with Product A initiation, with clinical i... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Clinical and Supply Chain Team,
Our integrated care system manages patients discharged on Product A for heart failure and Product B for chronic pain across 15 community clinics. and I am writing to raise two distinct concerns. The first is a clinical ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you send any recent peer-revie... |
SUBJECT: Unexpected reaction linked to Product A and supply inquiry
BODY:
Dear Customer Support,
As the pharmacy director of a 500-bed tertiary hospital and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 58 year old male with COPD. He ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient had an anaphylactic reaction with throat swelling and difficulty breathing temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Market access and patient impact of Product A and Product B
BODY:
Dear Quality Assurance and Commercial Teams,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. and I wish to raise two issues simultaneously.... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient developed severe photosensitivity with blistering after 14 days of continuous use temporally associated with Product A initiation, with ... |
SUBJECT: Safety and quality note on Product A and Product B
BODY:
Dear Drug Safety Department,
Our urgent care centre frequently dispenses Product A for acute migraine and Product B for nausea management in the same patient episodes. and I am formally reporting two concerns. The first is a safety issue with Product A.... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient experienced hypoglycemic episodes requiring emergency glucose administration temporally associated with Product A initiation, with clini... |
SUBJECT: Clinical observation with Product A and institutional inquiry
BODY:
Dear Clinical Lead Pharmacist,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Is ther... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any guidance on dose modification f... |
SUBJECT: Comprehensive inquiry on Product A and Product B
BODY:
Dear Pharmacy Director,
I am the pharmacy and therapeutics committee chair at a regional medical centre evaluating co-administration protocols for Product A and Product B in high-risk populations. and I wish to raise two issues simultaneously. The first i... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient developed severe photosensitivity with blistering after 14 days of continuous use temporally associated with Product A initiation, with ... |
SUBJECT: Request for details about Product A and institutional contract enquiry
BODY:
Dear Pharmacovigilance and Quality Officer,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I am writing to formally report two issues. The first is a product complaint regarding Product A where ou... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports a product quality defect in Product A where the tablets in the current batch are a visibly darker shade than all previous batches of the same strength in a specific identified bat... |
SUBJECT: Cross-product clinical and quality note on Product A and Product B
BODY:
Dear Healthcare Liaison,
I am the market access manager evaluating regional coverage for Product A in dermatology and Product B in rheumatology outpatient services. and I need to address two issues simultaneously. The first is a medical ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is Product A approved for pediatric... |
SUBJECT: Distribution and side-effect profile of Product A and supply inquiry
BODY:
Dear Compliance Team,
I am the ward manager on a busy medical unit and I have two distinct issues to address. The first concerns Product A where The patient is a 54 year old male with type 1 diabetes and peripheral neuropathy. He repor... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient reported hallucinations and confusion beginning on day 4 of the regimen temporally associated with Product A initiation, with clinical intervention ... |
SUBJECT: Administrative and medical query on Product A and supply inquiry
BODY:
Dear Product Team,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I am writing to formally report two issues. The first is a patient safety concern with Product A where The patient is a 36 year old fema... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the individual suffered from insomnia that progressed to near-total sleep deprivation over 1 week temporally associated with Product A initiation, with clinical... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Adverse Event Reporting Center,
Our urgent care centre frequently dispenses Product A for acute migraine and Product B for nausea management in the same patient episodes. and I am writing to raise two distinct concerns. The first is a clinical informa... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you clarify the pregnancy cate... |
SUBJECT: Inquiry and feedback about Product A and institutional inquiry
BODY:
Dear Customer Support,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Does Product A... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require premedication with an... |
SUBJECT: Urgent problem regarding Product A and Product B
BODY:
Dear Quality Officer,
Our supply chain team coordinates direct-to-ward deliveries of Product A for stroke units and Product B for orthopaedic wards across the National Health Trust. and I wish to bring two issues to your attention. The first is a medical ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any guidance on Product A u... |
SUBJECT: Product quality and adverse experience with Product A and Product B
BODY:
Dear Healthcare Liaison,
As the head of pharmacy procurement for a regional health trust, I am responsible for supply agreements covering Product A in haematology and Product B in gastroenterology. and I am writing to raise two distinct... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you provide the pharmacokinetic ... |
SUBJECT: Cross-product clinical and quality note on Product A and Product B
BODY:
Dear Integrated Quality and Safety Team,
As the pharmacy director of a 500-bed tertiary hospital, I am coordinating formulary reviews for Product A in cardiology and Product B in neurology. I have two separate concerns to raise. The firs... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What monitoring parameters are reco... |
SUBJECT: Clarification sought on Product A and Product B
BODY:
Dear Quality Officer,
As the medical liaison for Northshore Physicians Group, I coordinate care transitions involving Product A for respiratory conditions and Product B for cardiovascular protection. I have two distinct problems to raise. The first is an a... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient reported dyspnea and chest tightness within 30 minutes of ingestion temporally associated with Product A initiation, with clinical inter... |
SUBJECT: Comprehensive inquiry on Product A and supply inquiry
BODY:
Dear Medical Information and Safety Team,
I am the quality officer at a private hospital and I have two distinct issues to address. The first matters Product A where The patient is a 34 year old male previously healthy. He reported dyspnea and chest ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient reported dyspnea and chest tightness within 30 minutes of ingestion temporally associated with Product A initiation, with clinical intervention take... |
SUBJECT: Observation during use of Product A and Product B
BODY:
Dear Adverse Event Reporting Center,
I am the medical director of a residential care home group managing over 400 elderly residents across four facilities, several of whom are on Product A for hypertension and Product B for hyperlipidemia. and I am writi... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient developed Stevens-Johnson syndrome-like lesions across torso and arms temporally associated with Product A initiation, with clinical int... |
SUBJECT: Multi-faceted concern about Product A and Product B
BODY:
Dear Quality and Commercial Teams,
Our outpatient clinic manages a cohort of patients on Product A for anticoagulation and Product B for pain management after orthopaedic surgery. and I am writing to report two separate issues. The first involves Produ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient suffered from insomnia that progressed to near-total sleep deprivation over 1 week temporally associated with Product A initiation, with... |
SUBJECT: Integrated feedback regarding Product A and Product B
BODY:
To Whom It May Concern,
As the director of pharmacy for a network of community hospitals, I oversee the use of Product A in wound care and Product B in pain management protocols. I have two separate concerns to raise. The first is a clinical informat... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What is the recommended starting do... |
SUBJECT: Integrated feedback regarding Product A and Product B
BODY:
Dear Quality Officer,
Our urgent care centre frequently dispenses Product A for acute migraine and Product B for nausea management in the same patient episodes. and I am writing to formally report two distinct matters. Regarding Product A I need to c... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Does Product A require renal functi... |
SUBJECT: Cross-product clinical and quality note on Product A and supply inquiry
BODY:
Dear Post-Market Surveillance,
I am the director of pharmacy for a network of community hospitals and I am contacting you regarding two separate topics. The first is a safety report for Product A where The patient is a 45 year old m... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient suffered from persistent headaches that increased in intensity over 5 days temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Request for details about Product A and institutional inquiry
BODY:
Dear Healthcare Liaison,
I am the ward manager on a busy medical unit and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advisory committee is considering introduc... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any guidance on dose modification f... |
SUBJECT: Inquiry and feedback about Product A and supply inquiry
BODY:
Dear Pharmacovigilance and Quality Officer,
I am the lead clinical pharmacist at a regional oncology unit and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 57 year old male with slee... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient experienced hypoglycemic episodes requiring emergency glucose administration temporally associated with Product A initiation, with clinical interven... |
SUBJECT: Clarification sought on Product A and Product B
BODY:
Dear Integrated Quality and Safety Team,
Our paediatric ward currently uses Product A for seizure control and Product B for adjunctive behavioural management in selected patients. and I need to address two separate issues. Regarding Product A our clinical ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What adverse reactions are listed in... |
SUBJECT: Multi-faceted concern about Product A and institutional contract enquiry
BODY:
Dear Integrated Quality and Safety Team,
I am writing as the clinical coordinator for a multi-site renal network and I have two distinct issues to address. The first concerns Product A 50mg where our quality team found that several... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports a product quality defect in Product A where several tablets were chipped along the edges and had an off-white discoloration inconsistent with the product specification in a specif... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Clinical Coordinator,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outpatient pharmacies. and I am writing to formally raise two matters. The first concerns ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is Product A approved for pediatric ... |
SUBJECT: Healthcare provider memo on Product A and institutional inquiry
BODY:
Dear Quality Assurance and Commercial Teams,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I have two distinct issues to address. Regarding Product A for formulary evaluation, Are there any contraindica... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Are there any contraindications for Product ... |
SUBJECT: Labeling error and clinical query about Product A and Product B
BODY:
Dear Adverse Event Reporting Center,
I am writing as the clinical coordinator for a multi-site renal network where Product A is used for anaemia management and Product B for phosphate binding. and I am writing to report two separate issues.... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the subject reported hallucinations and confusion beginning on day 4 of the regimen temporally associated with Product A initiation, with clinical i... |
SUBJECT: Joint product evaluation and safety report for Product A and institutional inquiry
BODY:
Dear Medical Information Team,
I am the nurse practitioner in a busy GP practice and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically Could you clarify... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you clarify the pregnancy category and... |
SUBJECT: Multi-product safety and information request for Product A and institutional contract enquiry
BODY:
Dear Integrated Quality and Safety Team,
I am the ward manager on a busy medical unit and I have two distinct issues to address. The first concerns Product A 10mg where our quality team found that the ampoule n... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports a product quality defect in Product A where the ampoule neck shattered during attempted opening despite following the recommended technique in a specific identified batch with qua... |
SUBJECT: Healthcare provider memo on Product A and institutional inquiry
BODY:
Dear Medical Information and Safety Team,
I am the lead clinical pharmacist at a regional oncology unit and I have two distinct issues to address. Regarding Product A for formulary evaluation, Can you share data on the bioavailability of Pr... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share data on the bioavailability of... |
SUBJECT: Combined quality and clinical report for Product A and Product B
BODY:
Dear Safety Team,
I am the senior consultant at Global Health Partners advising on the combined formulary placement of Product A for oncology supportive care and Product B for nutritional supplementation. and I wish to bring two issues to ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Please provide the recommended stora... |
SUBJECT: Clarification sought on Product A and institutional inquiry
BODY:
Dear Medical Director,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where What is the recommended starti... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the recommended starting dose for Pr... |
SUBJECT: Co-therapy observation and commercial query on Product A and Product B
BODY:
Dear Patient Safety and Market Access Team,
I am the business development lead at MedCore Partners exploring joint procurement initiatives for Product A in nephrology and Product B in hepatology. and I need to address two separate is... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you send any recent peer-revie... |
SUBJECT: Pricing inquiry and safety signal for Product A and Product B
BODY:
Dear Clinical and Supply Chain Team,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. and I am formally reporting two concerns. The first ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient noticed dark tarry stools indicating possible gastrointestinal bleeding after 8 days temporally associated with Product A initiation, wi... |
SUBJECT: Product quality and adverse experience with Product A and Product B
BODY:
To Whom It May Concern,
I am writing as the clinical coordinator for a multi-site renal network where Product A is used for anaemia management and Product B for phosphate binding. and I am writing to report two separate issues. The firs... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient experienced profound fatigue and muscle weakness after 6 days of treatment temporally associated with Product A initiation, with clinica... |
SUBJECT: Follow-up needed for Product A and Product B
BODY:
Dear Regulatory Affairs,
I am the senior consultant at Global Health Partners advising on the combined formulary placement of Product A for oncology supportive care and Product B for nutritional supplementation. and I am contacting you about two separate matt... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you share data on the bioavaila... |
SUBJECT: Dual product inquiry and report about Product A and Product B
BODY:
Dear Healthcare Liaison,
I am the senior consultant at Global Health Partners advising on the combined formulary placement of Product A for oncology supportive care and Product B for nutritional supplementation. and I am formally reporting tw... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient developed new-onset atrial fibrillation within 72 hours temporally associated with Product A initiation, with clinical intervention and ... |
SUBJECT: Urgent concern regarding Product A and Product B
BODY:
Dear Regulatory Affairs,
As the institutional buyer for City Hospital Network, I am responsible for inventory planning that includes Product A for emergency resuscitation and Product B for chronic disease management. and I am writing to raise two distinct... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Please provide the immunogenicity ri... |
SUBJECT: Safety and quality note on Product A and institutional contract enquiry
BODY:
Dear Post-Market Surveillance,
I am the clinical lead pharmacist at a large teaching hospital and I am contacting you regarding two separate topics. The first is a product defect report for Product A where the batch number on the vi... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports a product quality defect in Product A where the batch number on the vial label did not match the corresponding entry in the electronic pedigree system in a specific identified bat... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Quality Officer,
Our integrated care system manages patients discharged on Product A for heart failure and Product B for chronic pain across 15 community clinics. and I need to address two separate issues. Regarding Product A our clinical team require... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What monitoring parameters are recom... |
SUBJECT: Observation during use of Product A and Product B
BODY:
Dear Medical Affairs,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. and I wish to raise two issues. The first concerns medical information about Product A specifi... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Does Product A require premedicatio... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Medical Director,
I am the quality officer at a private hospital where Product A is administered in the infusion centre and Product B is dispensed from the outpatient pharmacy. and I need to bring two matters to your attention. Regarding Product A The... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient reported dyspnea and chest tightness within 30 minutes of ingestion temporally associated with Product A initiation, with clinical inter... |
SUBJECT: Co-therapy observation and commercial query on Product A and supply inquiry
BODY:
Dear Patient Support,
I am the director of pharmacy for a network of community hospitals and I am contacting you regarding two separate topics. The first is a safety report for Product A where The patient is a 26 year old female... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient developed deep-vein thrombosis in the left calf within 2 weeks temporally associated with Product A initiation, with clinical intervention taken, qu... |
SUBJECT: Multi-product safety and information request for Product A and institutional contract enquiry
BODY:
Dear Compliance Team,
I am the chief pharmacist at a district general hospital and I wish to bring two matters to your attention. The first is a quality assurance issue with Product A 20mg where the oral syring... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports a product quality defect in Product A where the oral syringe provided in the kit had illegible graduation markings making accurate dosing impossible in a specific identified batch... |
SUBJECT: Pricing inquiry and safety signal for Product A and institutional contract enquiry
BODY:
Dear Integrated Quality and Safety Team,
I am the lead clinical pharmacist at a regional oncology unit and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 100mg where... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports a product quality defect in Product A where the foil strip was partially cut at an angle, leaving sharp edges that could injure patients during handling in a specific identified b... |
SUBJECT: Request for details about Product A and institutional contract enquiry
BODY:
Dear Adverse Event Reporting Center,
I am the prescribing advisor for a mental health trust and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 10mg where the foil strip was part... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports a product quality defect in Product A where the foil strip was partially cut at an angle, leaving sharp edges that could injure individuals during handling in a specific identifie... |
SUBJECT: Observation during use of Product A and Product B
BODY:
Dear Pharmacovigilance and Quality Officer,
Our outpatient clinic manages a cohort of patients on Product A for anticoagulation and Product B for pain management after orthopaedic surgery. and I need to address two separate issues. Regarding Product A ou... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What are the documented drug-drug in... |
SUBJECT: Issue reported with Product A and Product B
BODY:
Dear Post-Market Surveillance,
I am the lead clinical coordinator for a hospice network where Product A is used for chronic pain and Product B for breakthrough symptom control. and I need to address two issues simultaneously. The first is a medical information... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Are there any dietary restrictions ... |
SUBJECT: Market access and patient impact of Product A and Product B
BODY:
Dear Integrated Quality and Safety Team,
I am the nurse practitioner in a busy GP practice where we commonly co-prescribe Product A for depression and Product B for anxiety disorders. and I need to bring two matters to your attention. Regarding... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the individual experienced severe nausea and repeated vomiting starting on day 3 of therapy temporally associated with Product A initiation, with cl... |
SUBJECT: Healthcare provider memo on Product A and supply inquiry
BODY:
Dear Integrated Quality and Safety Team,
I am the medical director of a residential care home group managing over 400 elderly residents and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the individual showed signs of acute renal dysfunction with rising creatinine after 5 days temporally associated with Product A initiation, with clinical interv... |
SUBJECT: Healthcare provider memo on Product A and supply inquiry
BODY:
Dear Pharmacovigilance Team,
I am the lead clinical pharmacist at a regional oncology unit and I am writing to formally report two issues. The first is a patient safety issue with Product A where The patient is a 38 year old female with rheumatoid... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient developed bilateral hearing loss and persistent tinnitus after 11 days temporally associated with Product A initiation, with clinical intervention t... |
SUBJECT: Request for details about Product A and Product B
BODY:
Dear Integrated Quality and Safety Team,
As the institutional buyer for City Hospital Network, I am responsible for inventory planning that includes Product A for emergency resuscitation and Product B for chronic disease management. I have two distinct c... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient noticed dark tarry stools indicating possible gastrointestinal bleeding after 8 days temporally associated with Product A initiation, wi... |
SUBJECT: Integrated feedback regarding Product A and institutional contract enquiry
BODY:
Dear Compliance Team,
I am the lead clinical coordinator for a hospice network and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine dispensing inspection of our... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports a product quality defect in Product A where the ointment tube was severely swollen, suggesting a reaction between the product and the tube lining in a specific identified batch wi... |
SUBJECT: Request for details about Product A and Product B
BODY:
Dear Customer Support,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. I have two separate matters to raise. Firstly regarding Product A I would like to understand ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What adverse reactions are listed in... |
SUBJECT: Multi-product safety and information request for Product A and Product B
BODY:
Dear Medical and Commercial Teams,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. and I am writing to formally raise two matters. The first ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you provide guidance on dose t... |
SUBJECT: Labeling error and clinical query about Product A and Product B
BODY:
Dear Patient Support,
As the procurement lead for Alpha Hospital Consortium, I manage tenders that include Product A for critical care sedation and Product B for peri-operative analgesia. and I need to address two separate issues. Regarding... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What monitoring parameters are recom... |
SUBJECT: Comprehensive inquiry on Product A and Product B
BODY:
Dear Drug Safety and Medical Information,
As the pharmacy director of a 500-bed tertiary hospital, I am coordinating formulary reviews for Product A in cardiology and Product B in neurology. and I am writing to formally report two distinct matters. Regard... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is Product A approved for pediatric... |
SUBJECT: Multi-product safety and information request for Product A and institutional inquiry
BODY:
Dear Drug Safety and Medical Information,
I am the director of pharmacy for a network of community hospitals and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any real-world evidence on the long... |
SUBJECT: Pricing inquiry and safety signal for Product A and Product B
BODY:
Dear Quality Assurance and Commercial Teams,
As the formulary coordinator for a 300-bed community hospital, I manage requests for Product A in the respiratory clinic and Product B in the rheumatology service. and I am writing to formally repo... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Does Product A require renal functi... |
SUBJECT: Patient feedback concerning Product A and Product B
BODY:
Dear Healthcare Liaison,
I am the nurse practitioner in a busy GP practice where we commonly co-prescribe Product A for depression and Product B for anxiety disorders. and I wish to bring two issues to your attention. The first is a medical information... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is Product A approved for pediatric ... |
SUBJECT: Request for details about Product A and Product B
BODY:
Dear Clinical and Supply Chain Team,
Our urgent care centre frequently dispenses Product A for acute migraine and Product B for nausea management in the same patient episodes. and I need to address two issues simultaneously. The first is a medical inform... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you share data on the bioavaila... |
SUBJECT: Labeling error and clinical query about Product A and Product B
BODY:
Dear Pharmacovigilance Team,
I am the clinical pharmacy specialist in a busy emergency department where Product A is used for rapid anticoagulation reversal and Product B for gastric acid suppression. and I am writing to formally raise two ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require premedication... |
SUBJECT: Dual product inquiry and report about Product A and Product B
BODY:
Dear Medical Affairs,
I am the clinical pharmacy specialist in a busy emergency department where Product A is used for rapid anticoagulation reversal and Product B for gastric acid suppression. and I am contacting you about two separate matte... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What is the recommended starting do... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Pharmacovigilance and Quality Officer,
As the medical liaison for Northshore Physicians Group, I coordinate care transitions involving Product A for respiratory conditions and Product B for cardiovascular protection. and I wish to raise two issues. Th... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is there any guidance on dose modif... |
SUBJECT: Product quality and adverse experience with Product A and Product B
BODY:
Dear Clinical Coordinator,
I am the quality officer at a private hospital where Product A is administered in the infusion centre and Product B is dispensed from the outpatient pharmacy. I have two separate concerns to raise. The first i... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is there a black box warning or reg... |
SUBJECT: Product quality and adverse experience with Product A and institutional inquiry
BODY:
Dear Pharmacovigilance Team,
I am the medical director of a specialist cardiovascular centre and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical a... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any guidance on Product A use in pa... |
SUBJECT: Unexpected reaction linked to Product A and institutional contract enquiry
BODY:
Dear Regulatory Affairs,
I am the head of formulary and medicines optimisation for an integrated care board and I am contacting you regarding two separate topics. The first is a product defect report for Product A where the ampou... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where the ampoule neck shattered during attempted opening despite following the recommended technique in a specific identified batch with qua... |
SUBJECT: Clarification sought on Product A and Product B
BODY:
Dear Medical Information Team,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. and I need to address two separate issues. Regarding Product A our clinical team requir... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require renal functio... |
SUBJECT: Multi-product safety and information request for Product A and institutional contract enquiry
BODY:
Dear Patient Safety and Market Access Team,
I am the director of pharmacy for a network of community hospitals and I am writing to formally raise two separate matters. The first is a product quality concern ide... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the foil strip was partially cut at an angle, leaving sharp edges that could injure patients during handling in a specific identified b... |
SUBJECT: Safety and quality note on Product A and institutional contract enquiry
BODY:
Dear Medical Information and Safety Team,
I am writing as the clinical coordinator for a multi-site renal network and I am writing to formally raise two separate matters. The first is a product quality issue identified during routin... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the child-resistant cap failed to engage properly, raising serious safety concerns for household storage in a specific identified batch... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Patient Safety and Market Access Team,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outindividual pharmacies. and I am writing to formally report two distinc... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What is the recommended starting do... |
SUBJECT: Labeling error and clinical query about Product A and institutional inquiry
BODY:
Dear Medical Director,
As the head of pharmacy procurement for a regional health trust and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically What is the bioequ... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the bioequivalence data for the gene... |
SUBJECT: Request for details about Product A and institutional contract enquiry
BODY:
Dear Medical and Commercial Teams,
I am the clinical pharmacist for a long-term care facility and I have two distinct issues to address. The first concerns Product A 20mg where our quality team found that the outer box was water-dama... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports a product quality defect in Product A where the outer box was water-damaged during transit, affecting the legibility of dosage instructions printed on the flap in a specific ident... |
SUBJECT: Labeling error and clinical query about Product A and Product B
BODY:
Dear Clinical and Supply Chain Team,
I am the nurse practitioner in a busy GP practice where we commonly co-prescribe Product A for depression and Product B for anxiety disorders. and I am contacting you about two separate matters. The firs... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you provide a summary of clinic... |
SUBJECT: Packaging defect and dosing question for Product A and supply inquiry
BODY:
Dear Quality Officer,
I am the head of formulary and medicines optimisation for an integrated care board and I have two distinct issues to address. The first concerns Product A where The patient is a 45 year old male with no known dru... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient noticed yellowing of sclera and skin suggestive of hepatic involvement after 10 days temporally associated with Product A initiation, with clinical ... |
SUBJECT: Packaging defect and dosing question for Product A and Product B
BODY:
Dear Medical and Commercial Teams,
I am the clinical pharmacy specialist in a busy emergency department where Product A is used for rapid anticoagulation reversal and Product B for gastric acid suppression. and I wish to bring two issues t... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you provide a summary of clinica... |
SUBJECT: Distribution and side-effect profile of Product A and institutional contract enquiry
BODY:
To Whom It May Concern,
I am the nurse practitioner in a busy GP practice and I am contacting you regarding two separate topics. The first is a product defect report for Product A where the cartridge contained visible f... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the cartridge contained visible fibrils or precipitate that should not have been present in a specific identified batch with quarantine... |
SUBJECT: Clarification sought on Product A and institutional contract enquiry
BODY:
Dear Quality Assurance Team,
As the head of pharmacy procurement for a regional health trust and I have two distinct issues to address. The first concerns Product A 25mg where our quality team found that the cap of the dropper bottle w... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports a product quality defect in Product A where the cap of the dropper bottle was cross-threaded and could not be sealed tightly after opening in a specific identified batch with quar... |
SUBJECT: Issue reported with Product A and Product B
BODY:
Dear Medical and Commercial Teams,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. and I am writing to formally report two distinct matters. Regarding Prod... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Please provide the recommended stor... |
SUBJECT: Packaging defect and dosing question for Product A and Product B
BODY:
Dear Safety Team,
I am the clinical pharmacy specialist in a busy emergency department where Product A is used for rapid anticoagulation reversal and Product B for gastric acid suppression. I have two separate concerns to raise. The first ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you provide a summary of clinic... |
SUBJECT: Integrated feedback regarding Product A and Product B
BODY:
Dear Clinical and Supply Chain Team,
I am the ward manager on a busy medical unit where several inpatients are currently receiving Product A for infection prophylaxis alongside Product B for gastric protection. and I am writing to formally report two... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Does Product A require premedicatio... |
SUBJECT: Combined quality and clinical report for Product A and institutional contract enquiry
BODY:
Dear Medical Information Team,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I have two distinct issues to address. The first matters Product A 20mg where our quality team found th... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where the adhesive on the secondary label failed, causing it to detach from the primary container surface in a specific identified batch with... |
SUBJECT: Follow-up needed for Product A and institutional inquiry
BODY:
Dear Quality Officer,
As the pharmacy director of a 500-bed tertiary hospital and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically What is the recommended starting dose for Prod... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the recommended starting dose for Pr... |
SUBJECT: Clinical observation with Product A and institutional inquiry
BODY:
Dear Clinical Affairs,
I am writing as the clinical coordinator for a multi-site renal network and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Does Product A require ... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require premedication with an... |
SUBJECT: Multi-product safety and information request for Product A and institutional contract enquiry
BODY:
Dear Medical and Commercial Teams,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I am writing to formally raise two separate matters. The first is a product quality problem... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports a product quality defect in Product A where a vial arrived with a cracked neck, causing leakage of approximately 2 ml of solution in a specific identified batch with quarantined s... |
SUBJECT: Packaging defect and dosing question for Product A and Product B
BODY:
Dear Pharmacy Director,
As the institutional buyer for City Hospital Network, I am responsible for inventory planning that includes Product A for emergency resuscitation and Product B for chronic disease management. and I wish to raise two... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What are the documented drug-drug i... |
SUBJECT: Patient feedback concerning Product A and supply inquiry
BODY:
Dear Quality Officer,
I am the director of pharmacy for a network of community hospitals and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 53 year old female with... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient developed severe photosensitivity with blistering after 14 days of continuous use temporally associated with Product A initiation, with clinical int... |
SUBJECT: Healthcare provider memo on Product A and institutional inquiry
BODY:
Dear Clinical Lead Pharmacist,
I am the ward manager on a busy medical unit and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically Could you send any recent peer-reviewed p... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you send any recent peer-reviewed publ... |
SUBJECT: Complex issue involving Product A and institutional contract enquiry
BODY:
Dear Pharmacovigilance Team,
I am the medical director of a residential care home group managing over 400 elderly residents and I am writing to formally raise two separate matters. The first is a product quality issue identified during... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where the label on the outer carton displayed an incorrect batch number compared to the inner foil strip in a specific identified batch with ... |
SUBJECT: Inquiry and feedback about Product A and institutional inquiry
BODY:
Dear Patient Support,
I am the lead clinical coordinator for a hospice network and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically Can you provide a summary of clinical t... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you provide a summary of clinical trials... |
SUBJECT: Multi-product safety and information request for Product A and Product B
BODY:
Dear Patient Support,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. and I need to address two issues simultaneously. The first is a medical... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What monitoring parameters are reco... |
SUBJECT: Observation during use of Product A and institutional inquiry
BODY:
Dear Medical Information Team,
I am the clinical pharmacy specialist in a busy emergency department and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Could you provide ... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you provide the maximum recommended da... |
SUBJECT: Safety and quality note on Product A and Product B
BODY:
Dear Clinical Affairs,
I am the market access manager evaluating regional coverage for Product A in dermatology and Product B in rheumatology outpatient services. and I need to address two issues simultaneously. The first is a medical information query ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What is the bioequivalence data for... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.